ΠΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅, Π³ΠΎΡΠΌΠΎΠ½Π°Π»ΡΠ½ΡΠ΅ ΠΈ ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² ΠΏΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ
Π Π΄Π°Π½Π½ΠΎΠΉ ΡΠ°Π±ΠΎΡΠ΅ Π²ΠΏΠ΅ΡΠ²ΡΠ΅ Π² ΠΎΡΠ΅ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΠΏΡΠ°ΠΊΡΠΈΠΊΠ΅ ΠΈΠ·ΡΡΠ΅Π½Π° ΡΡΡΠΎΡΠ½Π°Ρ ΡΠ΅ΠΊΡΠ΅ΡΠΈΡ ΠΌΠ΅Π»Π°ΡΠΎΠ½ΠΈΠ½Π°, ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Π° Π΅Π³ΠΎ Π²Π·Π°ΠΈΠΌΠΎΡΠ²ΡΠ·Ρ ΡΠΎ ΡΡΠ΅ΠΏΠ΅Π½ΡΡ Π΄Π½Π΅Π²Π½ΠΎΠΉ ΡΠΎΠ½Π»ΠΈΠ²ΠΎΡΡΠΈ ΠΈ ΡΡΠ΅ΠΏΠ΅Π½ΡΡ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² Ρ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΠΎΠΉ. ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Ρ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΏΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ, Π²ΡΠ΄Π΅Π»Π΅Π½ ΡΡΠ΄ ΠΏΡΠΎΠ³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈΡ ΡΠ°ΠΊΡΠΎΡΠΎΠ², ΡΠ²Π΅Π»ΠΈΡΠΈΠ²Π°ΡΡΠΈΡ ΡΠΈΡΠΊ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ. ΠΡΠΎΠ²Π΅Π΄Π΅Π½ Π°Π½Π°Π»ΠΈΠ·… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
- Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- ΠΡΠ΄Π΅ΡΠΆΠΊΠ°
- ΠΠΈΡΠ΅ΡΠ°ΡΡΡΠ°
- ΠΡΡΠ³ΠΈΠ΅ ΡΠ°Π±ΠΎΡΡ
- ΠΠΎΠΌΠΎΡΡ Π² Π½Π°ΠΏΠΈΡΠ°Π½ΠΈΠΈ
Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- Π‘ΠΠΠ‘ΠΠ Π‘ΠΠΠ ΠΠ©ΠΠΠΠ
- ΠΠΠΠΠ 1. ΠΠΠΠΠ ΠΠΠ’ΠΠ ΠΠ’Π£Π Π«
- 1. 1. ΠΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΠ° Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ²: Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ°, Π»Π΅ΡΠ΅Π½ΠΈΠ΅ ΠΈ Π²Π΅Π΄Π΅Π½ΠΈΠ΅
- 1. 2. ΠΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΠ΅ ΠΈ ΡΠ°ΡΡΡΡΠΎΠΉΡΡΠ²ΠΎ ΠΏΠΈΡΠ΅Π²ΠΎΠ³ΠΎ ΠΏΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ
- 1. 1. 3. ΠΠΎΠ²ΡΡΠ΅Π½Π½Π°Ρ Π΄Π½Π΅Π²Π½Π°Ρ ΡΠΎΠ½Π»ΠΈΠ²ΠΎΡΡΡ Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² ΠΏΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ
- 2. 1. ΠΠ»ΠΈΠ½ΠΈΠΊΠΎ-Π°Π½ΡΡΠΎΠΏΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠ°Ρ Ρ Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠ° ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Π½ΡΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ²
- 2. 2. ΠΠ΅ΡΠΎΠ΄Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ
- 3. 1. Π Π°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΠΎΡΡΡ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ ΡΡΠ΅Π΄ΠΈ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² ΠΏΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ
- 3. 2. ΠΠ»ΠΈΡΠ½ΠΈΠ΅ ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ ΡΠ°ΠΊΡΠΎΡΠΎΠ² Π½Π° ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΏΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ
- 3. 3. Π Π΅ΡΡΠΎΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· Π°Π½ΡΡΠΎΠΏΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΡ Π΄Π°Π½Π½ΡΡ Π΄ΠΎ ΠΈ ΠΏΠΎΡΠ»Π΅ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠ²Π½ΠΎΠ³ΠΎ Π²ΠΌΠ΅ΡΠ°ΡΠ΅Π»ΡΡΡΠ²Π° Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² Ρ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΠΎΠΉ
- 3. 4. ΠΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ Π»ΠΈΠΏΠΈΠ΄Π½ΠΎΠ³ΠΎ ΠΎΠ±ΠΌΠ΅Π½Π° Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² ΠΏΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ
- 3. 5. ΠΠ΅ΠΏΡΠΈΠ½ ΠΏΡΠΈ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠΌ ΠΈ ΠΊΠΎΠ½ΡΡΠΈΡΡΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎ-ΡΠΊΠ·ΠΎΠ³Π΅Π½Π½ΠΎΠΌ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΠΈ Ρ Π΄Π΅ΡΠ΅ΠΉ
- 3. 6. Π‘ΠΎΡΡΠΎΡΠ½ΠΈΠ΅ ΡΠ³Π»Π΅Π²ΠΎΠ΄Π½ΠΎΠ³ΠΎ ΠΎΠ±ΠΌΠ΅Π½Π° Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² ΠΏΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ
- 3. 7. Π‘Π΅ΠΊΡΠ΅ΡΠΈΡ ΠΌΠ΅Π»Π°ΡΠΎΠ½ΠΈΠ½Π° Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² ΠΏΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ
ΠΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅, Π³ΠΎΡΠΌΠΎΠ½Π°Π»ΡΠ½ΡΠ΅ ΠΈ ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² ΠΏΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ (ΡΠ΅ΡΠ΅ΡΠ°Ρ, ΠΊΡΡΡΠΎΠ²Π°Ρ, Π΄ΠΈΠΏΠ»ΠΎΠΌ, ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½Π°Ρ)
ΠΠΠ’Π£ΠΠΠ¬ΠΠΠ‘Π’Π¬ ΠΠ ΠΠΠΠΠΠ«.
ΠΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΠ° — ΡΠ΅Π΄ΠΊΠ°Ρ ΡΠΌΠ±ΡΠΈΠΎΠ³Π΅Π½Π½Π°Ρ ΠΎΠΏΡΡ ΠΎΠ»Ρ Ρ ΠΈΠ°Π·ΠΌΠ°Π»ΡΠ½ΠΎ-ΡΠ΅Π»Π»ΡΡΠ½ΠΎΠΉ ΠΎΠ±Π»Π°ΡΡΠΈ Ρ Π½ΠΈΠ·ΠΊΠΎΠΉ ΡΡΠ΅ΠΏΠ΅Π½ΡΡ ΠΌΠ°Π»ΠΈΠ³Π½ΠΈΠ·Π°ΡΠΈΠΈ (WHO Π) ΠΈ Π²ΡΡΠΎΠΊΠΎΠΉ ΡΠ°ΡΡΠΎΡΠΎΠΉ ΡΠ΅ΡΠΈΠ΄ΠΈΠ²ΠΈΡΠΎΠ²Π°Π½ΠΈΡ, ΡΠ°Π·Π²ΠΈΠ²Π°ΡΡΠ°ΡΡΡ Π²ΡΠ»Π΅Π΄ΡΡΠ²ΠΈΠ΅ Π½Π°ΡΡΡΠ΅Π½ΠΈΡ ΠΏΡΠΎΡΠ΅ΡΡΠ° ΠΈΠ½Π²ΠΎΠ»ΡΡΠΈΠΈ ΡΠΌΠ±ΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΡ ΠΊΠ»Π΅ΡΠΎΠΊ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΡΡΠΈ (ΠΊΠ°ΡΠΌΠ°Π½Π° Π Π°ΡΠΊΠ΅) [79, 151]. ΠΡΠΈ ΠΎΠ±ΡΠ΅ΠΉ ΡΠ°ΡΡΠΎΡΠ΅ Π²ΠΎΠ·Π½ΠΈΠΊΠ½ΠΎΠ²Π΅Π½ΠΈΡ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ Π² 0,5−2 Π½ΠΎΠ²ΡΡ ΡΠ»ΡΡΠ°Π΅Π² Π½Π° ΠΌΠΈΠ»Π»ΠΈΠΎΠ½ Π½Π°ΡΠ΅Π»Π΅Π½ΠΈΡ Π² Π³ΠΎΠ΄, 30−50% Π²ΡΠ΅Ρ ΡΠ»ΡΡΠ°Π΅Π² Π½Π°Π±Π»ΡΠ΄Π°ΡΡΡΡ Π² Π΄Π΅ΡΡΠΊΠΎΠΌ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ²ΠΎΠΌ Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ [129, 131]. Π£ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² ΠΏΠΈΠΊ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π΅ΠΌΠΎΡΡΠΈ ΠΏΡΠΈΡ ΠΎΠ΄ΠΈΡΡΡ Π½Π° Π²ΠΎΠ·ΡΠ°ΡΡ ΠΎΡ 5 Π΄ΠΎ 14 Π»Π΅Ρ, ΠΎΠ΄Π½Π°ΠΊΠΎ ΠΎΠΏΡΡ ΠΎΠ»Ρ ΠΌΠΎΠΆΠ΅Ρ ΠΌΠ°Π½ΠΈΡΠ΅ΡΡΠΈΡΠΎΠ²Π°ΡΡ Π² Π»ΡΠ±ΠΎΠΌ Π²ΠΎΠ·ΡΠ°ΡΡΠ΅, Π²ΠΊΠ»ΡΡΠ°Ρ ΠΏΡΠ΅ΠΈ Π½Π΅ΠΎΠ½Π°ΡΠ°Π»ΡΠ½ΡΠΉ ΠΏΠ΅ΡΠΈΠΎΠ΄ [79].
ΠΠ΅ΡΠΌΠΎΡΡΡ Π½Π° Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΡΠΉ ΠΈΡΡ ΠΎΠ΄ ΠΈ ΡΠ΄ΠΎΠ²Π»Π΅ΡΠ²ΠΎΡΠΈΡΠ΅Π»ΡΠ½ΡΠ΅ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ Π»Π΅ΡΠ΅Π½ΠΈΡ, ΠΊΠ°ΡΠ΅ΡΡΠ²ΠΎ ΠΆΠΈΠ·Π½ΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΡΠ½ΠΈΠΆΠ°Π΅ΡΡΡ ΠΈΠ·-Π·Π° ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ, ΡΠ²ΡΠ·Π°Π½Π½ΡΡ Ρ Π°Π½Π°ΡΠΎΠΌΠΈΡΠ΅ΡΠΊΠΎΠΉ Π±Π»ΠΈΠ·ΠΎΡΡΡΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ ΠΊ Π·ΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠΌΡ Π½Π΅ΡΠ²Ρ, Π·ΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ Ρ ΠΈΠ°Π·ΠΌΠ΅, Π³ΠΈΠΏΠΎΡΠΈΠ·Ρ ΠΈ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΡΡΡ [1, 79, 116]. Π‘ΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΠ΅ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ Π³ΠΎΡΠΌΠΎΠ½Π°Π»ΡΠ½ΠΎΠΉ Π·Π°ΠΌΠ΅ΡΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΡΡ Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎ ΡΠ»ΡΡΡΠΈΡΡ ΠΊΠ°ΡΠ΅ΡΡΠ²ΠΎ ΠΆΠΈΠ·Π½ΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ², ΠΎΠΏΠ΅ΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΠΏΠΎ ΠΏΠΎΠ²ΠΎΠ΄Ρ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ.
ΠΠΎΠ²ΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΠ΅ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΡΡΠ°, ΡΠ²ΡΠ·Π°Π½Π½ΠΎΠ΅ Ρ ΠΈΠ½ΡΠΈΠ»ΡΡΡΠ°ΡΠΈΠ²Π½ΡΠΌΠΈ ΠΏΡΠΎΡΠ΅ΡΡΠ°ΠΌΠΈ, ΠΎΠΏΡΡ ΠΎΠ»ΡΠΌΠΈ ΠΈ ΠΏΠΎΡΠ»Π΅Π΄ΡΡΠ²ΠΈΡΠΌΠΈ Π»Π΅ΡΠ΅Π½ΠΈΡ ΡΠ°ΡΡΠΎ ΠΏΡΠΈΠ²ΠΎΠ΄ΠΈΡ ΠΊ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ, Ρ Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΡΡΡΠ΅Π³ΠΎΡΡ Π±ΡΡΡΡΡΠΌ ΠΈ Π½Π΅ΡΠΊΠ»ΠΎΠ½Π½ΡΠΌ Π½Π°ΡΠ°ΡΡΠ°Π½ΠΈΠ΅ΠΌ Π²Π΅ΡΠ°. ΠΠ΄Π½ΠΎΠΉ ΠΈΠ· Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΡΠ°ΡΡΡΡ ΠΏΡΠΈΡΠΈΠ½ ΡΠ°Π·Π²ΠΈΡΠΈΡ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² ΡΠ²Π»ΡΠ΅ΡΡΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΠ°. Π Π°Π·Π²ΠΈΡΠΈΠ΅ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ Π½Π°Π±Π»ΡΠ΄Π°Π΅ΡΡΡ Ρ 25−60% Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² ΠΏΠΎΡΠ»Π΅ Ρ ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ ΠΈ ΠΎΠΊΠ°Π·ΡΠ²Π°Π΅Ρ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ Π²Π΅ΡΠΎΠΌΠΎΠ΅ ΠΎΡΡΠΈΡΠ°ΡΠ΅Π»ΡΠ½ΠΎΠ΅ Π²Π»ΠΈΡΠ½ΠΈΠ΅ Π½Π° ΠΊΠ°ΡΠ΅ΡΡΠ²ΠΎ ΠΆΠΈΠ·Π½ΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² [72, 130].
ΠΡΠΈΠ±Π°Π²ΠΊΠ° Π²Π΅ΡΠ° ΠΏΡΠΎΠΈΡΡ ΠΎΠ΄ΠΈΡ Π² ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ΅ Π½Π°ΡΡΡΠ΅Π½ΠΈΡ ΡΡΠ½ΠΊΡΠΈΠΎΠ½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΡΠ΅Π½ΡΡΠΎΠ² Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΡΡΠ°, ΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΡΡ Π·Π° Π½Π°ΡΡΡΠ΅Π½ΠΈΠ΅, ΡΡΠ²ΡΡΠ²ΠΎ Π³ΠΎΠ»ΠΎΠ΄Π° ΠΈ ΡΠ½Π΅ΡΠ³Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠΉ Π±Π°Π»Π°Π½Ρ, ΡΡΠΎ ΠΏΡΠΈΠ²ΠΎΠ΄ΠΈΡ ΠΊ Π³ΠΈΠΏΠ΅ΡΡΠ°Π³ΠΈΠΈ, Π²Π΅Π³Π΅ΡΠ°ΡΠΈΠ²Π½ΡΠΌ Π½Π°ΡΡΡΠ΅Π½ΠΈΡΠΌ, ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΡ ΡΠΊΠΎΡΠΎΡΡΠΈ ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΈΡ ΠΏΡΠΎΡΠ΅ΡΡΠΎΠ², Π³ΠΈΠΏΠΎΠΏΠΈΡΡΠΈΡΠ°ΡΠΈΠ·ΠΌΡ, ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΡ ΡΠΈΠ·ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΈ Π³ΠΈΠΏΠ΅ΡΡΠΎΠΌΠ½ΠΈΠΈ. ΠΡΠΈ ΡΡΠΎΠΌ ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ Π½Π°Π΄ Π²Π΅ΡΠΎΠΌ ΠΏΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈ Π½Π΅Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎ Π΄ΠΎΠ±ΠΈΡΡΡΡ ΠΏΡΡΠ΅ΠΌ ΡΠΎΠ±Π»ΡΠ΄Π΅Π½ΠΈΡ Π΄ΠΈΠ΅ΡΡ ΠΈ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΎΠ±ΡΠ°Π·Π° ΠΆΠΈΠ·Π½ΠΈ. Π‘Π»Π΅Π΄ΡΠ΅Ρ ΠΏΠΎΠ΄ΡΠ΅ΡΠΊΠ½ΡΡΡ, ΡΡΠΎ Π² Π½Π°ΡΡΠΎΡΡΠ΅Π΅ Π²ΡΠ΅ΠΌΡ Π½Π΅ ΡΡΡΠ΅ΡΡΠ²ΡΠ΅Ρ ΠΎΠ±ΡΠ΅ΠΏΡΠΈΠ½ΡΡΠΎΠΉ ΡΠ°ΡΠΌΠ°ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² ΠΏΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ, ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΊΠΎΡΠΎΡΠΎΠΉ Π±ΡΠ»Π° Π±Ρ ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π΅Π½Π° ΠΊΠΎΠ½ΡΡΠΎΠ»ΠΈΡΡΠ΅ΠΌΡΠΌΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡΠΌΠΈ.
Π’Π°ΠΊΠΈΠΌ ΠΎΠ±ΡΠ°Π·ΠΎΠΌ, ΠΏΠΎΠ½ΠΈΠΌΠ°Π½ΠΈΠ΅ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π° Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ Π½Π΅ΡΠΎΠΌΠ½Π΅Π½Π½ΠΎ ΡΠΌΠΎΠΆΠ΅Ρ ΡΠ»ΡΡΡΠΈΡΡ ΠΏΠΎΠ½ΠΈΠΌΠ°Π½ΠΈΠ΅ ΠΌΠ΅Ρ Π°Π½ΠΈΠ·ΠΌΠΎΠ² ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΈ ΠΊΠΎΠ½ΡΡΠΈΡΡΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎ-ΡΠΊΠ·ΠΎΠ³Π΅Π½Π½ΠΎΠ³ΠΎ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ.
Π¦ΠΠΠ¬ ΠΠ‘Π‘ΠΠΠΠΠΠΠΠΠ―:
ΠΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ½ΠΎΠ΅ ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ , Π³ΠΎΡΠΌΠΎΠ½Π°Π»ΡΠ½ΡΡ ΠΈ ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΈΡ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠ΅ΠΉ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² ΠΏΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ.
ΠΠΠΠΠ§Π:
1. ΠΡΡΠ²ΠΈΡΡ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΠΎΡΡΡ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΏΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ ΠΈ ΠΏΡΠΎΠ²Π΅ΡΡΠΈ Π°Π½Π°Π»ΠΈΠ· Π°Π½ΡΡΠΎΠΏΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΡ Π΄Π°Π½Π½ΡΡ Π΄ΠΎ ΠΈ ΠΏΠΎΡΠ»Π΅ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠ²Π½ΠΎΠ³ΠΎ Π²ΠΌΠ΅ΡΠ°ΡΠ΅Π»ΡΡΡΠ²Π°.
2. ΠΠ·ΡΡΠΈΡΡ Π²Π»ΠΈΡΠ½ΠΈΠ΅ ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ ΡΠ°ΠΊΡΠΎΡΠΎΠ² Π½Π° ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΏΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ.
3. ΠΡΠΎΠ²Π΅ΡΡΠΈ Π°Π½Π°Π»ΠΈΠ· ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ Π»ΠΈΠΏΠΈΠ΄Π½ΠΎΠ³ΠΎ ΠΈ ΡΠ³Π»Π΅Π²ΠΎΠ΄Π½ΠΎΠ³ΠΎ ΠΎΠ±ΠΌΠ΅Π½Π° ΠΏΡΠΈ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² ΠΏΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ.
4. ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΡ ΡΠΈΡΠΊΠ°Π΄Π½ΡΠΉ ΡΠΈΡΠΌ ΡΠ΅ΠΊΡΠ΅ΡΠΈΠΈ ΠΌΠ΅Π»Π°ΡΠΎΠ½ΠΈΠ½Π° Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² ΠΏΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ.
ΠΠΠ£Π§ΠΠΠ― ΠΠΠΠΠΠΠ.
Π Π΄Π°Π½Π½ΠΎΠΉ ΡΠ°Π±ΠΎΡΠ΅ Π²ΠΏΠ΅ΡΠ²ΡΠ΅ Π² ΠΎΡΠ΅ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΠΏΡΠ°ΠΊΡΠΈΠΊΠ΅ ΠΈΠ·ΡΡΠ΅Π½Π° ΡΡΡΠΎΡΠ½Π°Ρ ΡΠ΅ΠΊΡΠ΅ΡΠΈΡ ΠΌΠ΅Π»Π°ΡΠΎΠ½ΠΈΠ½Π°, ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Π° Π΅Π³ΠΎ Π²Π·Π°ΠΈΠΌΠΎΡΠ²ΡΠ·Ρ ΡΠΎ ΡΡΠ΅ΠΏΠ΅Π½ΡΡ Π΄Π½Π΅Π²Π½ΠΎΠΉ ΡΠΎΠ½Π»ΠΈΠ²ΠΎΡΡΠΈ ΠΈ ΡΡΠ΅ΠΏΠ΅Π½ΡΡ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² Ρ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΠΎΠΉ. ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Ρ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΏΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ, Π²ΡΠ΄Π΅Π»Π΅Π½ ΡΡΠ΄ ΠΏΡΠΎΠ³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈΡ ΡΠ°ΠΊΡΠΎΡΠΎΠ², ΡΠ²Π΅Π»ΠΈΡΠΈΠ²Π°ΡΡΠΈΡ ΡΠΈΡΠΊ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ. ΠΡΠΎΠ²Π΅Π΄Π΅Π½ Π°Π½Π°Π»ΠΈΠ· Π°Π½ΡΡΠΎΠΏΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΡ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² Ρ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΠΎΠΉ Π΄ΠΎ ΠΈ ΠΏΠΎΡΠ»Π΅ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠ²Π½ΠΎΠ³ΠΎ Π²ΠΌΠ΅ΡΠ°ΡΠ΅Π»ΡΡΡΠ²Π° ΠΈ Π²ΡΡΠ²Π»Π΅Π½ ΡΡΠ΄ Π·Π°ΠΊΠΎΠ½ΠΎΠΌΠ΅ΡΠ½ΠΎΡΡΠ΅ΠΉ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ ΡΠΎΡΡΠΎ-Π²Π΅ΡΠΎΠ²ΡΡ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ. ΠΠΎΠ»ΡΡΠ΅Π½Ρ Π΄Π°Π½Π½ΡΠ΅ ΠΎΠ± ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΡΡ Π»ΠΈΠΏΠΈΠ΄Π½ΠΎΠ³ΠΎ ΠΈ ΡΠ³Π»Π΅Π²ΠΎΠ΄Π½ΠΎΠ³ΠΎ ΠΎΠ±ΠΌΠ΅Π½Π° Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² Ρ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΏΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ.
ΠΠΠ£Π§ΠΠ-ΠΠ ΠΠΠ’ΠΠ§ΠΠ‘ΠΠΠ ΠΠΠΠ§ΠΠΠΠ:
ΠΠΎΠ»ΡΡΠ΅Π½Ρ Π΄Π°Π½Π½ΡΠ΅ ΠΎ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΠΎΡΡΠΈ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ ΡΡΠ΅Π΄ΠΈ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² ΠΏΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ. Π£ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½Ρ ΡΠ°ΠΊΡΠΎΡΡ, ΡΠ²Π΅Π»ΠΈΡΠΈΠ²Π°ΡΡΠΈΠ΅ ΡΠΈΡΠΊ ΡΠ°Π·Π²ΠΈΡΠΈΡ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ, ΡΠ°ΠΊΠΈΠ΅ ΠΊΠ°ΠΊ Π»ΠΎΠΊΠ°Π»ΠΈΠ·Π°ΡΠΈΡ ΠΎΠΏΡΡ ΠΎΠ»ΠΈ, Π²ΠΈΠ΄ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠ²Π½ΠΎΠ³ΠΎ Π²ΠΌΠ΅ΡΠ°ΡΠ΅Π»ΡΡΡΠ²Π°, Π²ΠΎΠ²Π»Π΅ΡΠ΅Π½ΠΈΠ΅ Π² ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΏΡΠΎΡΠ΅ΡΡ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΎΠ±Π»Π°ΡΡΠΈ.
ΠΡΡΠ²Π»Π΅Π½Ρ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΡΠ΅ Π½Π°ΡΡΡΠ΅Π½ΠΈΡ Π»ΠΈΠΏΠΈΠ΄Π½ΠΎΠ³ΠΎ ΠΎΠ±ΠΌΠ΅Π½Π° Π²Π½Π΅ Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΠΎΡ ΠΠΠ’ Ρ Π²ΡΠ΅Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² ΠΏΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ.
ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΠ΅ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΎΠ±Π»Π°ΡΡΠΈ ΠΏΡΠ΅Π΄ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ΅Ρ ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ Π½Π°ΡΡΡΠ΅Π½ΠΈΠΉ ΡΠ³Π»Π΅Π²ΠΎΠ΄Π½ΠΎΠ³ΠΎ ΠΎΠ±ΠΌΠ΅Π½Π° Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² ΠΏΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ Π²Π½Π΅ Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΠΎΡ ΠΠΠ’, ΡΡΠΎ ΠΏΡΠΎΡΠ²Π»ΡΠ΅ΡΡΡ Π³ΠΈΠΏΠ΅ΡΠΈΠ½ΡΡΠ»ΠΈΠ½Π΅ΠΌΠΈΠ΅ΠΉ, ΠΈΠ½ΡΡΠ»ΠΈΠ½ΠΎΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΡΡ ΠΈ Π³ΠΈΠΏΠ΅ΡΠ»Π΅ΠΏΡΠΈΠ½Π΅ΠΌΠΈΠ΅ΠΉ.
ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ ΡΡΡΠΎΡΠ½ΡΠΉ ΡΠΈΡΠΌΠ° ΡΠ΅ΠΊΡΠ΅ΡΠΈΠΈ ΠΌΠ΅Π»Π°ΡΠΎΠ½ΠΈΠ½Π° ΠΈ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½Π° ΡΡΠ±ΡΠ΅ΠΊΡΠΈΠ²Π½Π°Ρ ΠΎΡΠ΅Π½ΠΊΠ° Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΠΎΡΡΠΈ Π΄Π½Π΅Π²Π½ΠΎΠΉ ΡΠΎΠ½Π»ΠΈΠ²ΠΎΡΡΠΈ Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΏΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ. ΠΡΡΠ²Π»Π΅Π½ΠΎ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΠΎΠ΅ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ Π½ΠΎΡΠ½ΠΎΠ³ΠΎ ΠΌΠ΅Π»Π°ΡΠΎΠ½ΠΈΠ½Π°, ΠΊΠΎΡΠΎΡΠΎΠ΅ ΠΈΠΌΠ΅Π΅Ρ Π²Π·Π°ΠΈΠΌΠΎΡΠ²ΡΠ·Ρ ΡΠΎ ΡΡΠ΅ΠΏΠ΅Π½ΡΡ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ ΠΈ ΡΡΠ΅ΠΏΠ΅Π½ΡΡ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΠΎΡΡΠΈ Π΄Π½Π΅Π²Π½ΠΎΠΉ ΡΠΎΠ½Π»ΠΈΠ²ΠΎΡΡΠΈ.
ΠΠ«ΠΠΠΠ«.
1. Π Π°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΠΎΡΡΡ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² ΠΏΠΎΡΠ»Π΅ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ Π²ΠΌΠ΅ΡΠ°ΡΠ΅Π»ΡΡΡΠ²Π° ΠΏΠΎ ΠΏΠΎΠ²ΠΎΠ΄Ρ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ ΡΠΎΡΡΠ°Π²Π»ΡΠ΅Ρ 30%.
2. ΠΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΠ΅ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ ΡΠ°ΡΠ΅ ΡΠ°Π·Π²ΠΈΠ²Π°Π΅ΡΡΡ ΠΏΡΠΈ ΠΈΠ½ΡΡΠ°-ΡΠΊΡΡΡΠ°Π²Π΅Π½ΡΡΠΈΠΊΡΠ»ΡΡΠ½ΠΎΠΉ Π»ΠΎΠΊΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ ΠΎΠΏΡΡ ΠΎΠ»ΠΈ (40%), ΡΡΠ°Π½ΡΠΊΡΠ°Π½ΠΈΠ°Π»ΡΠ½ΠΎΠΌ Π΄ΠΎΡΡΡΠΏΠ΅ ΠΏΡΠΈ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΈ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠ²Π½ΠΎΠ³ΠΎ Π²ΠΌΠ΅ΡΠ°ΡΠ΅Π»ΡΡΡΠ²Π° (90%) ΠΈ ΠΏΡΠΈ Π½Π°Π»ΠΈΡΠΈΠΈ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΡ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΎΠ±Π»Π°ΡΡΠΈ (75%).
3. ΠΡΠΈ ΡΠ΅ΡΡΠΎΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠΌ Π°Π½Π°Π»ΠΈΠ·Π΅ Π°Π½ΡΡΠΎΠΏΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΡ Π΄Π°Π½Π½ΡΡ Π±ΡΠ»ΠΎ Π²ΡΡΠ²Π»Π΅Π½ΠΎ, ΡΡΠΎ Ρ Π²ΡΠ΅Ρ Π΄Π΅ΡΠ΅ΠΉ Ρ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΠΎΠΉ ΠΏΡΠΎΠ³ΡΠ΅ΡΡΠΈΡΡΡΡΠ΅Π΅ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ ΡΠ΅ΠΌΠΏΠΎΠ² ΡΠΎΡΡΠ° Π½Π°Π±Π»ΡΠ΄Π°Π΅ΡΡΡ Ρ ΡΠ΅Π΄ΡΠΌΠΎΠ³ΠΎ ΠΌΠ΅ΡΡΡΠ° ΠΆΠΈΠ·Π½ΠΈΠΏΡΠΎΠ³ΡΠ΅ΡΡΠΈΡΡΡΡΠ΅Π΅ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠ΅ Π²Π΅ΡΠ° Ρ Π΄Π΅ΡΠ΅ΠΉ Ρ ΠΏΠΎΠ²ΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΠ΅ΠΌ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΎΠ±Π»Π°ΡΡΠΈ (Π² ΠΎΡΠ»ΠΈΡΠΈΠΈ ΠΎΡ Π΄Π΅ΡΠ΅ΠΉ Ρ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΠΎΠΉ Π±Π΅Π· ΠΏΠΎΠ²ΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΡ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΡΡΠ°) ΠΎΡΠΌΠ΅ΡΠ°Π΅ΡΡΡ ΠΏΠΎΡΠ»Π΅ ΠΏΡΡΠΈ Π»Π΅Ρ ΠΆΠΈΠ·Π½ΠΈ.
4. ΠΠ΅ΡΠ΅ΠΉ Ρ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΠΎΠΉ ΠΈ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΏΠΎΠ²ΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΠ΅ΠΌ ΠΏΡΠΈ ΡΠΎΠΏΠΎΡΡΠ°Π²ΠΈΠΌΡΡ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΡ ΠΠΠ ΠΠΠ’ ΠΎΡΠ»ΠΈΡΠ°ΡΡ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ Π±ΠΎΠ»Π΅Π΅ Π²ΡΡΠ°ΠΆΠ΅Π½Π½Π°Ρ Π³ΠΈΠΏΠ΅ΡΠ»Π΅ΠΏΡΠΈΠ½Π΅ΠΌΠΈΡ, Π° ΡΠ°ΠΊΠΆΠ΅ Π³ΠΈΠΏΠ΅ΡΠΈΠ½ΡΡΠ»ΠΈΠ½Π΅ΠΌΠΈΡ ΠΈ ΠΈΠ½ΡΡΠ»ΠΈΠ½ΠΎΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΡ (ΡΠ΅Π½Π΄Π΅Π½ΡΠΈΡ ΠΊ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎΡΡΠΈ ΡΠ°Π·Π»ΠΈΡΠΈΠΉ) ΠΏΡΠΈ ΡΡΠ°Π²Π½Π΅Π½ΠΈΠΈ Ρ Π΄Π΅ΡΡΠΌΠΈ Ρ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΠΎΠΉ Π±Π΅Π· ΠΏΠΎΠ²ΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΡ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΡΡΠ°.
5. Π£ Π΄Π΅ΡΠ΅ΠΉ Ρ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΏΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ ΡΠ°ΡΡΠΎΡΠ° Π²ΡΡΡΠ΅ΡΠ°Π΅ΠΌΠΎΡΡΠΈ ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ° ΡΠΎΡΡΠ°Π²ΠΈΠ»Π° 85%, ΡΡΠΎ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ ΠΏΡΠ΅Π²ΡΡΠ°Π΅Ρ ΡΠ°ΡΡΠΎΡΡ ΡΠΊΠ°Π·Π°Π½Π½ΡΡ Π½Π°ΡΡΡΠ΅Π½ΠΈΠΉ Ρ Π΄Π΅ΡΠ΅ΠΉ Ρ ΠΠΠ (52%).
6. Π£ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² ΠΏΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ Π²ΡΡΠ²Π»Π΅Π½Ρ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΡΠ΅ Π½Π°ΡΡΡΠ΅Π½ΠΈΡ Π»ΠΈΠΏΠΈΠ΄Π½ΠΎΠ³ΠΎ ΠΎΠ±ΠΌΠ΅Π½Π° Π²Π½Π΅ Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΠΎΡ ΠΠΠ’: Π΄ΠΈΡΠ»ΠΈΠΏΠΈΠ΄Π΅ΠΌΠΈΡ Π²ΡΡΠ²Π»Π΅Π½Π° Ρ 90% Π΄Π΅ΡΠ΅ΠΉ Ρ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΈ Ρ 77% Π΄Π΅ΡΠ΅ΠΉ Ρ Π½ΠΎΡΠΌΠ°Π»ΡΠ½ΡΠΌ Π²Π΅ΡΠΎΠΌ.
7. Π£ Π΄Π΅ΡΠ΅ΠΉ ΠΏΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ Π²ΡΡΠ²Π»Π΅Π½ΠΎ Π½Π°ΡΡΡΠ΅Π½ΠΈΠ΅ ΡΡΡΠΎΡΠ½ΠΎΠ³ΠΎ ΡΠΈΡΠΌΠ° ΡΠ΅ΠΊΡΠ΅ΡΠΈΠΈ ΠΌΠ΅Π»Π°ΡΠΎΠ½ΠΈΠ½Π°, ΠΊΠΎΡΠΎΡΠΎΠ΅ Π²ΡΡΠ°ΠΆΠ°Π΅ΡΡΡ Π² ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠΈ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ Π½ΠΎΡΠ½ΠΎΠ³ΠΎ ΠΈ ΡΡΡΠ΅Π½Π½Π΅Π³ΠΎ ΠΌΠ΅Π»Π°ΡΠΎΠ½ΠΈΠ½Π° ΠΈ ΠΈΠΌΠ΅Π΅Ρ ΠΎΠ±ΡΠ°ΡΠ½ΡΡ ΠΊΠΎΡΡΠ΅Π»ΡΡΠΈΠΎΠ½Π½ΡΡ ΡΠ²ΡΠ·Ρ ΡΠΎ ΡΡΠ΅ΠΏΠ΅Π½ΡΡ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ ΠΈ ΡΡΠ΅ΠΏΠ΅Π½ΡΡ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΠΎΡΡΠΈ Π΄Π½Π΅Π²Π½ΠΎΠΉ ΡΠΎΠ½Π»ΠΈΠ²ΠΎΡΡΠΈ.
ΠΠ ΠΠΠ’ΠΠ§ΠΠ‘ΠΠΠ Π ΠΠΠΠΠΠΠΠΠ¦ΠΠ.
Π£ Π²ΡΠ΅Ρ Π΄Π΅ΡΠ΅ΠΉ, ΠΏΠ΅ΡΠ΅Π½Π΅ΡΡΠΈΡ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠ²Π½ΠΎΠ΅ Π²ΠΌΠ΅ΡΠ°ΡΠ΅Π»ΡΡΡΠ²ΠΎ ΠΏΠΎ ΠΏΠΎΠ²ΠΎΠ΄Ρ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ, ΠΏΠΎΠΌΠΈΠΌΠΎ ΠΎΠ±ΡΠ΅ΠΏΡΠΈΠ½ΡΡΡΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ, Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΡΡ Π½Π° Π²ΡΡΠ²Π»Π΅Π½ΠΈΠ΅ Π½Π°ΡΡΡΠ΅Π½ΠΈΠΉ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΎ-Π³ΠΈΠΏΠΎΡΠΈΠ·Π°ΡΠ½ΡΡ ΡΡΠ½ΠΊΡΠΈΠΉ, Π½Π΅ΠΎΠ±Ρ ΠΎΠ΄ΠΈΠΌΠΎ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ ΡΠ΅Π³ΡΠ»ΡΡΠ½ΠΎΠ³ΠΎ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ Π»ΠΈΠΏΠΈΠ΄Π½ΠΎΠ³ΠΎ ΠΎΠ±ΠΌΠ΅Π½Π° ΠΈ Π½Π°Π·Π½Π°ΡΠ΅Π½ΠΈΠ΅ Π³ΠΈΠΏΠΎΡ ΠΎΠ»Π΅ΡΡΠ΅ΡΠΈΠ½ΠΎΠ²ΠΎΠΉ Π΄ΠΈΠ΅ΡΡ Π² ΡΠ°Π½Π½ΠΈΠ΅ ΡΡΠΎΠΊΠΈ ΠΏΠΎΡΠ»Π΅ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΈ, Π½Π΅Π·Π°Π²ΠΈΡΠΈΠΌΠΎ ΠΎΡ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ ΠΠΠ’.
ΠΡΠ΅ Π΄Π΅ΡΠΈ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΈ ΠΏΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ ΠΎΡΠ½ΠΎΡΡΡΡΡ ΠΊ Π³ΡΡΠΏΠΏΠ΅ Π²ΡΡΠΎΠΊΠΎΠ³ΠΎ ΡΠΈΡΠΊΠ° ΡΠ°Π·Π²ΠΈΡΠΈΡ ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎ-ΡΠΎΡΡΠ΄ΠΈΡΡΡΡ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ, ΡΡΠΎ ΡΡΠ΅Π±ΡΠ΅Ρ ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΡΡΡΠ΅Π³ΠΎ ΠΎΠ±ΡΠ΅ΠΌΠ° ΠΈ ΡΡΠΎΠΊΠΎΠ² Π΄ΠΈΠ½Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΡ.
ΠΠ½ΡΡΠ°-ΡΠΊΡΡΡΠ°Π²Π΅Π½ΡΡΠΈΠΊΡΠ»ΡΡΠ½Π°Ρ Π»ΠΎΠΊΠ°Π»ΠΈΠ·Π°ΡΠΈΡ ΠΎΠΏΡΡ ΠΎΠ»ΠΈ, ΡΡΠ°Π½ΡΠΊΡΠ°Π½ΠΈΠ°Π»ΡΠ½ΡΠΉ Π΄ΠΎΡΡΡΠΏ ΠΏΡΠΈ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠ²Π½ΠΎΠΌ Π²ΠΌΠ΅ΡΠ°ΡΠ΅Π»ΡΡΡΠ²Π΅, Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΏΠΎΠ²ΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΠ΅, ΠΏΡΠΎΠ³ΡΠ΅ΡΡΠΈΡΡΡΡΠ΅Π΅ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠ΅ Π²Π΅ΡΠ° (ΠΏΡΠΈ ΠΏΠΎΠ²ΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΠΈ Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΎΠ±Π»Π°ΡΡΠΈ) ΠΏΠΎΡΠ»Π΅ ΠΏΡΡΠΈ Π»Π΅Ρ ΠΆΠΈΠ·Π½ΠΈ, ΠΏΠΎΠ²ΡΡΠ΅Π½Π½ΡΠΉ ΠΠΠ ΠΠΠ’ Π½Π° ΠΌΠΎΠΌΠ΅Π½Ρ ΠΏΠΎΡΡΠ°Π½ΠΎΠ²ΠΊΠΈ Π΄ΠΈΠ°Π³Π½ΠΎΠ·Π° ΡΠ²Π»ΡΡΡΡΡ Π²Π°ΠΆΠ½ΡΠΌΠΈ ΠΏΡΠΎΠ³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΡΠ°ΠΊΡΠΎΡΠ°ΠΌΠΈ ΡΠΈΡΠΊΠ° ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ Ρ Π΄Π΅ΡΠ΅ΠΉ Ρ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΠΎΠΉ, ΡΡΠΎ ΠΏΠΎΠ·Π²ΠΎΠ»ΠΈΡ Π² ΡΠ°Π½Π½ΠΈΠ΅ ΡΡΠΎΠΊΠΈ ΠΏΠΎΡΠ»Π΅ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΈ ΡΠΊΠΎΡΡΠ΅ΠΊΡΠΈΡΠΎΠ²Π°ΡΡ ΠΏΠΈΡΠ°Π½ΠΈΠ΅ ΠΈ ΠΎΠ±ΡΠ°Π· ΠΆΠΈΠ·Π½ΠΈ.
Π‘Π½ΠΈΠΆΠ΅Π½ΠΈΠ΅ ΡΠ΅ΠΌΠΏΠΎΠ² ΡΠΎΡΡΠ° ΡΠ΅Π±Π΅Π½ΠΊΠ° Ρ ΡΠ΅Π΄ΡΠΌΠΎΠ³ΠΎ ΠΌΠ΅ΡΡΡΠ° ΠΆΠΈΠ·Π½ΠΈ ΠΌΠΎΠΆΠ΅Ρ Π±ΡΡΡ ΠΎΠ΄Π½ΠΈΠΌ ΠΈΠ· ΡΠ°Π½Π½ΠΈΡ ΡΠΈΠΌΠΏΡΠΎΠΌΠΎΠ² ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ³ΠΈΠΎΠΌΡ ΠΈ ΡΡΠ΅Π±ΡΠ΅Ρ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ.
Π Π΄Π°Π»ΡΠ½Π΅ΠΉΡΠ΅ΠΌ ΠΏΠ΅ΡΠ΅Π΄ Π²ΡΠ°ΡΠ°ΠΌΠΈ ΠΎΡΠΊΡΡΠ²Π°Π΅ΡΡΡ ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Π° ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΌΠ΅Π»Π°ΡΠΎΠ½ΠΈΠ½Π° Π΄Π»Ρ ΠΊΠΎΡΡΠ΅ΠΊΡΠΈΠΈ Π³ΠΈΠΏΠ΅ΡΡΠΎΠΌΠ½ΠΈΠΈ ΠΈ, Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎ, Π³ΠΈΠΏΠΎΡΠ°Π»Π°ΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² ΠΏΠΎΡΠ»Π΅ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ. ΠΠ»Ρ ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π΅Π½ΠΈΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΈ Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΡΡΠΈ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΠΌΠ΅Π»Π°ΡΠΎΠ½ΠΈΠ½Π° Ρ Π΄Π΅ΡΠ΅ΠΉ Π½Π΅ΠΎΠ±Ρ ΠΎΠ΄ΠΈΠΌΠΎ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠ΅ Π΄Π°Π»ΡΠ½Π΅ΠΉΡΠΈΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ Π² ΡΡΠΎΠΉ ΠΎΠ±Π»Π°ΡΡΠΈ.
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- ΠΠΎΡΠ΅Π»ΡΡΠ΅Π² Π‘.Π. ΠΠΏΡΡ ΠΎΠ»ΠΈ Ρ ΠΈΠ°Π·ΠΌΡ ΠΈ Π΄Π½Π° III ΠΆΠ΅Π»ΡΠ΄ΠΎΡΠΊΠ°: ΠΠ²ΡΠΎΡΠ΅Ρ. Π΄ΠΈΡΡ. .Π΄ΠΎΠΊΡΠΎΡΠ° ΠΌΠ΅Π΄. Π½Π°ΡΠΊ. Π. -2001.
- ΠΠΎΠ½ΠΎΠ²Π°Π»ΠΎΠ² Π.Π., ΠΠΎΡΠ΅Π»ΡΡΠ΅Π² Π‘. Π. ΠΡΠ΅Π½ΠΊΠ° ΡΠ°Π΄ΠΈΠΊΠ°Π»ΡΠ½ΠΎΡΡΠΈ ΡΠ΄Π°Π»Π΅Π½ΠΈΡ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌ III ΠΆΠ΅Π»ΡΠ΄ΠΎΡΠΊΠ° Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΡΠ΅ ΠΈΡΡΠΎΡΠ½ΠΈΠΊΠΈ ΠΏΡΠΎΠ΄ΠΎΠ»ΠΆΠ΅Π½Π½ΠΎΠ³ΠΎ ΡΠΎΡΡΠ° ΠΈ ΡΠ΅ΡΠΈΠ΄ΠΈΠ²ΠΎΠ². // ΠΠΎΠΏΡ. Π½Π΅ΠΉΡΠΎΡ ΠΈΡ.- 1988 № 6.- Π‘. 712.
- ΠΠ°Π·Π΅ΡΠΊΠΈΠ½Π° H.A. Π‘ΠΎΠΌΠ°ΡΠΎΡΡΠΎΠΏΠ½Π°Ρ ΡΡΠ½ΠΊΡΠΈΡ Π³ΠΈΠΏΠΎΡΠΈΠ·Π° ΠΈ ΠΏΠ΅ΡΠΈΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΡΡΠΎΠ²ΡΠ΅ ΡΠ°ΠΊΡΠΎΡΡ Ρ Π΄Π΅ΡΠ΅ΠΉ Ρ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΠΎΠΉ: ΠΡΡΠΎΡΠ΅Ρ. Π΄ΠΈΡΡ. .ΠΊΠ°Π½Π΄. ΠΌΠ΅Π΄. Π½Π°ΡΠΊ Π., 1996.
- ΠΠ°ΡΠΎΠ²Π° Π.Π., ΠΠ°Π±Π°ΡΠΈΠ½Π° Π. Π. ΠΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½Π°Ρ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ° ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ. // Π ΡΠ±ΠΎΡΠ½ΠΈΠΊΠ΅: ΠΠΆΠΈΡΠ΅Π½ΠΈΠ΅. ΠΡΠΈΠΎΠ»ΠΎΠ³ΠΈΡ, ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·, ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π°ΡΠΏΠ΅ΠΊΡΡ. Π ΡΠΊΠΎΠ²ΠΎΠ΄ΡΡΠ²ΠΎ Π΄Π»Ρ Π²ΡΠ°ΡΠ΅ΠΉ. Π Π΅Π΄. ΠΠ΅Π΄ΠΎΠ² Π. Π., ΠΠ΅Π»ΡΠ½ΠΈΡΠ΅Π½ΠΊΠΎ Π. Π. Π. -ΠΠΠ 2004- Π‘. 354−358.
- ΠΠ΅ΡΠ΅ΡΠΊΠΎΠ²Π° Π.Π., Π Π΅ΠΌΠΈΠ·ΠΎΠ² Π. Π. ΠΠΆΠΈΡΠ΅Π½ΠΈΠ΅ Π² Π΄Π΅ΡΡΠΊΠΎΠΌ Π²ΠΎΠ·ΡΠ°ΡΡΠ΅. // Π ΡΠ±ΠΎΡΠ½ΠΈΠΊΠ΅: ΠΠΆΠΈΡΠ΅Π½ΠΈΠ΅. ΠΠΎΠ΄ ΡΠ΅Π΄. ΠΠ΅Π΄ΠΎΠ²Π° Π. Π., ΠΠ΅Π»ΡΠ½ΠΈΡΠ΅Π½ΠΊΠΎ Π. Π. Π., 2004, Π‘. 312−328.
- Π‘Π΅ΠΌΠ΅Π½ΠΎΠ²Π° Π.Π. ΠΠΈΠ³Π°Π½ΡΡΠΊΠΈΠ΅ ΠΊΠΈΡΡΠΎΠ·Π½ΡΠ΅ ΠΊΡΠ°Π½ΠΈΠΎΡΠ°ΡΠΈΠ½Π³ΠΈΠΎΠΌΡ Ρ Π΄Π΅ΡΠ΅ΠΉ: ΠΠ²ΡΠΎΡΠ΅Ρ. Π΄ΠΈΡΡ. .ΠΊΠ°Π½Π΄. ΠΌΠ΅Π΄. Π½Π°ΡΠΊ Π., 1992.
- Π‘ΡΠ°ΡΠΊΠΎΠ²Π° H.Π’., ΠΠΈΡΡΠΊΠΎΠ²Π° E.B. ΠΠΆΠΈΡΠ΅Π½ΠΈΠ΅ y ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ². // Π ΡΠ±ΠΎΡΠ½ΠΈΠΊΠ΅: ΠΠΆΠΈΡΠ΅Π½ΠΈΠ΅. ΠΠΎΠ΄ ΡΠ΅Π΄. ΠΠ΅Π΄ΠΎΠ²Π° Π. Π., ΠΠ΅Π»ΡΠ½ΠΈΡΠ΅Π½ΠΊΠΎ Π. Π. Π., 2004, Π‘. 330 348.
- Ahmet A., Blaser S., Stephens D. et al. Weight gain in craniopharyngioma a model for hypothalamic obesity. // J. Pediatr. Endocrinol. Metab. — 2006 -Vol. 19(2) -P.121−7.
- Anderson M., Salmon M. Symptomatic cataplexy. // Journal of Neurology Neurosurgery and Psychiatry 1977 — Vol. 40(2) — P. 186−191.
- Asian I.R., Ranadive S.A., Ersoy B.A. et al. Bariatric surgery in a patient with complete MC4R deficiency. // In. t J. Obes. 2011 — Vol. 35 — P. 457−461.
- Balkan Π., Steffens A.B. et al. Hyperinsulinemia and glucose tolerance in obese rats with lesions of the ventromedial hypothalamus: dependence on food intake and route of administration. // Metabolism 1991 — Vol. 40 -P. 1092−1100.
- Baltasar A., Serra Π‘., Bou R. et al. Sleeve gastrectomy in a 10-year-old Child. // Obes. Surg. 2008 — Vol. 18 — P. 733−736.
- Barazzoni R. et al. Hyperleptinemia prevents increased plasma ghrelin concentration during short-term moderate caloric restriction in rats. // Gastroenterology-2003 Vol.124-P. 1188−1192.
- Becker G., Kortmann R.D., Skalej M. et al. The role of radiotherapy in the treatment of craniopharyngeoma indications, results, side effects. // Frontiers of Radiation Therapy and Oncology — 1999 — Vol. 33 — P. 100−13.
- Birketvedt G., Florholmen J., Sundsfjord J. et al. Behavioral and neuroendocrine characteristics of the night-eating syndrome. // Journal of the American Medical Association 1999 — Vol. 282(7) — P. 657−663.
- Bloch K.E., Schoch O.D. et al. German version of the Epworth Sleepiness Scale. // Respiration 1999 — Vol. 66 — P. 440−447.
- Bray G.A. Syndromes of hypothalamic obesity in man. // Pediatr. Ann. 1984 — Vol. 13-P. 525−536.
- Bray G.A., Gallagher T.F. et al. Manifestations of hypothalamic obesity in man: a comprehensive investigation of eight patients and a review of the literature. // Medicine (Baltimore) 1975 — Vol. 54 — P. 301−330.
- Bray G.A., Hollander P., Klein S. et al. A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. // Obes. Res. 2003 — Vol. 11 — P. 722−733.
- Bray G.A., Inoue S., Nishizawa Y. Hypothalamic obesity. The autonomic hypothesis and the lateral hypothalamus. // Diabetologia 1981 — Vol. 20 — P. 366−377.
- Bray G.A., York D.A. Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. // Physiol. Rev. 1979 -Vol. 59-P. 719−809.
- Bruch H. The Frohlich syndrome: report of the original case. // Obes. Res. -1939- Vol.1-P.329−331.
- Brzezinski A. Melatonin in humans. // New England Journal of Medicine -1997 Vol. 336(3) — P. 86−195.
- Caro J.F., Kolaczynski J.W. et al. Decreased cerebrospinal fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. // Lancet 1996 -Vol. 348 -P. 159−161.
- Chemelli R.M., Willie J.T. et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. // Cell 1999 — Vol. 98(4) — P. 437 451.
- Choux M., Lena G., Genitori L. et al. Craniopharyngioma in children. // Neurochirurgie 1991 — Vol. 37(1) — P. 1−174.
- Coll A.P., Farooqi I.S., Challis B.G. et al. Proopiomelanocortin and energy balance: insights from human and murine genetics. // J. Clin. Endocrinol. Metab. 2004 — Vol. 89 — P. 2557−2562.
- Combs S.E., Thilmann C., Huber P.E. et al. Achievement of long-term local control in patients with craniopharyngiomas using high precision stereotactic radio- therapy. // Cancer 2007 — Vol. 109 — P. 2308 -2314.
- Cone R.D. Anatomy and regulation of the central melanocortin system. // Nature Neuroscience 2005 — Vol. 8(5) — P. 571−8.
- Considine R.V., Sinha M.K., Heiman M.L. et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. // N. Engl. J. Med. 1996 — Vol. 334 — P. 292−295.
- Crom D.B., Smith D., Xiong Z. et al. Health status in long-term survivors of pediatric craniopharyngiomas. // J. Neurosci. Nurs. 2010 — Vol. 42(6) — P. 323−8.
- Crowley R.K., Hamnvik O.P. et al. Morbidity and mortality in patients with craniopharyngioma after surgery. // Clinical Endocrinology 2010 — Vol. 73(4)-P. 516−21.
- Cushing H. Intracranial Tumorous. Notes upon a series of two thousand verified cases with surgical mortality precentages pertaining therato. // Springfield- 1932.
- D’Cruz O.F., Vaughn B.V., Gold S.H. et al. Symptomatic cataplexy in pontomedullary lesions. //Neurology 1994 — Vol. 44(11) — P. 2189−2191.
- Dan D., Harnanan D., Seetahal S. et al. Bariatric surgery in the management of childhood obesity: should there be an age limit? // Obes. Surg. 2010 -Vol.20 — P. 114−117.
- Danielsson P., Janson A. et al. Impact of sibutramine therapy in children with hypothalamic obesity or obesity with aggravating syndromes. // J. Clin. Endocrinol. Metab. 2007 — Vol. 92 — P. 4101−4106.
- Daousi C., Dunn A.J., Foy P.M. et al. Endocrine and neuroanatomic features associated with weight gain and obesity in adult patients with hypothalamic damage. // Am. J. Med. 2005 — Vol. 118 — P. 45−50.
- Daousi C., MacFarlane I.A., English P.J. et al. Is there a role for ghrelin and peptide-YY in the pathogenesis of obesity in adults with acquired structural hypothalamic damage? // J. Clin. Endocrinol. Metab. 2005 — Vol. 90 — P. 5025−5030.
- Despres J.P. The endocannabinoid system: a new target for the regulation of energy balance and metabolism. // Crit. Pathw. Cardiol. 2007 — Vol. 6 — P. 46−50.
- DeVile C.J., Grant D.B. et al. Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging. // J. Clin. Endocrinol. Metab. 1996 — Vol. 81(7) — P. 347.
- DeVile C.J., Grant D.B. et al. Growth and endocrine sequelae of craniopharyngioma. // Archives of Disease in Childhood 1996 — Vol. 75(2) -P. 108−14.
- Ethelberg S. On cataplexy in a case of frontal lobe tumour. // Acta Psychiatrica et Neurologica 1949 — Vol. 24(3−4) — P. 421−427.
- Fahlbusch R., Honegger J., Paulus W. et al. Surgical treatment of craniopharyngiomas: experience with 168 patients. // J. Neurosurg. 1999 -Vol. 90(2) — P. 237−50.
- Farooqi I.S., Jebb S.A. et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. // N. Engl. J. Med. 1999 — 341 — P. 913 915.
- Farooqi I.S., O’Rahilly S. Genetics of obesity in humans. // Endocr. Rev. -2006-Vol. 27-P. 710−718.
- Farooqi I.S. et al. Obesity genes-its all about parents. // Cell Metab. 2009 -Vol. 9-P. 48788.
- Fernandes J.K., Klein M.J. et al. Triiodothyronine supplementation for hypothalamic obesity. //Metabolism 2002 — Vol. 51 — P. 1381−1383.
- Fery F., Plat L. et al. Impaired counterregulation of glucose in a patient with hypothalamic sarcoidosis. // N. Engl. J. Med. 1999 — Vol. 340 — P. 852 856.
- Fisher P.G., Jenab J. et al. Outcomes and failure patterns in childhood craniopharyngiomas. // Childs Nerv. Syst. 1998 — Vol. 14(10) — P. 558−63.
- Friebe D., Neef M., Kratzsch J. et al. Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans. // Diabetologia-2011 Vol. 54-P. 1200−1211.
- Friedberg M., Zoumakis E. et al. Modulation of 11 beta-hydroxysteroid dehydrogenase type 1 in mature human subcutaneous adipocytes by hypothalamic messengers. // J. Clin. Endocrinol. Metab. 2003 — Vol. 88 — P. 385−393.
- Friedland O., Nemet D., Gorodnitsky N. et al. Obesity and lipid profiles in children and adolescents. // J. Pediatr. Endocrin. Metab. 2002 — Vol. 15 — P. 1011−1016.
- Frohman L.A., Bernardis L.L. et al. Plasma insulin and triglyceride levels after hypothalamic lesions in wean-ling rats. // Am. J. Physiol. 1969 — Vol. 216-P. 1496−1501.
- Gadde K.M., Franciscy D.M., Wagner H.R. et al. Zonisamide for weight loss in obese adults: a randomized controlled trial. // JAMA 2003 — Vol. 289 -P. 1820−1825.
- Greenway F.L., Bray G.A. Treatment of hypothalamic obesity with caffeine and ephedrine. //Endocr. Pract. 2008 — Vol. 14 — P. 697−703.
- Guran T., Turan S. et al. The role of leptin, soluble leptin receptor, resistin, and insulin secretory dynamics in the pathogenesis of hypothalamic obesity in children. // Eur. J. Pediatr. 2009 — Vol. 168(9) — P. 1043−8.
- Habrand J.L., Saran F., Alapetite C. et al. Radiation therapy in the management of craniopharyngioma: current concepts and futuredevelopments. // J. Pediatr. Endocrinol. Metab. 2006 — Vol. 19 (suppl. 1) -P. 389−394.
- Haluzik M., Fiedler J., Nedvidkova J. Serum leptin levels in patients with hyperlipidemias. // Nutrition 2000 — Vol. 16 — P. 429−433.
- Han P.W., Frohman L.A. Hyperinsulinemia in tube-fed hypophy-sectomized rats bearing hypothalamic lesions. // Am. J. Physiol. 1970 — Vol. 219 — P. 1632−1636.
- Harz K.J., Muller H.L., Waldeck E. et al. Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity. // J. Clin. Endocrinol. Metab. 2003 — Vol. 88 -P. 5227−5231.
- Haupt R., Magnani C., Pavanello M. et al. Epidemiological aspects of craniopharyngioma. // J. Pediatr. Endocrinol. Metab. 2006 — Vol. 19 (suppl. 1)-P. 289−93.
- Hetherington A.W., Ranson S.W. Hypothalamic lesions and adiposity in the rat. // The Anatomical Record 1940 — Vol. 78(2) — P. 149−72.
- Heymsfield S.B., Greenberg A.S., Fujioka K. et al. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. // JAMA 1999 — Vol. 282 — P. 1568−1575.
- Himpens J., Dapri G., Cadiere G.B. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. // Obes. Surg. 2006 — Vol. 16 — P. 1450−1456.
- Hofmann B.M. et al. Nuclear beta-catenin accumulation as reliable marker for the differentiation between cystic craniopharyngiomas and rathke cleft cysts: A clinico-pathologic approach. // Am. J. Surg. Pathol. 2006 — Vol. 30 — P. 1595−603.
- Honegger J., Buchfelder M., Fahlbusch R. Surgical treatment of craniopharyngiomas: endocrinological results. // Journal of Neurosurgery -1999-Vol. 90(2)-P. 251−7.
- Inge T.H., Pfluger P., Zeller M. et al. Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy. // Nat. Clin. Pract. Endocrinol. Metab. 2007 — Vol. 3 — P. 606−609.
- Inoue S., Bray G.A. The effects of subdiaphragmatic vagotomy in rats with ventromedial hypothalamic obesity. // Endocrinology 1977 — Vol. 100 — P. 108−114.
- Ismail D., O’Connell M.A., Zacharin M.R. Dexamphetamine use for management of obesity and hypersomnolence following hypothalamic injury. // J. Pediatr. Endocrinol. Metab. 2006 — Vol. 19(2) — P. 129−34.
- Iughetti L., Bruzzi P. Obesity and craniopharyngioma. // Ital. J. Pediatr. -2011-Vol. 37-P. 38.
- John J., Wu M.F. et al. Systemic administration of hypocretin-1 reduces cataplexy andnormalizes sleep and waking durations in narcoleptic dogs. // Sleep Research Online 2002 — Vol. 3(1) — P. 2823−2825.
- Karavitaki N., Cudlip S., Adams C.B. et al. Craniopharyngiomas. // Endocr. Rev. 2006 — Vol. 27(4) — P. 371−97.
- Karavitaki N., Warner J.T. et al. GH replacement does not increase the risk of recurrence in patients with craniopharyngioma. // Clin. Endocrinol. (Oxf) -2006 Vol. 64(5) — P. 556−60.
- Kavazarakis E., Moustaki M. et al. Relation of Serum Leptin Levels to Lipid Profile in Healthy Children. // Metabolism 2001 — Vol. 50(9) — P. 10 911 094.
- King B.M. The rise, fall, and resurrection of the ventromedial hypothalamus in the regulation of feeding behavior and body weight. // Physiol. Behav. -2006-Vol. 87-P. 221−244.
- Kobayashi T. Long-term results of gamma knife radiosurgery for 100 consecutive cases of craniopharyngioma and a treatment strategy. // Prog. Neurol. Surg. 2009 — Vol. 22 — P. 63−76.
- Korner A., Kratzsch J. et al. New predictors of the metabolic syndrome in children role of adipocytokines. // Pediatr. Res. — 2007 — Vol. 61 — P. 640 645.
- Korner A., Kratzsch J., Kiess W. Adipocytokines: leptin the classical, resistin — the controversical, adiponectin — the promising, and more to come. // Best Pract. Res. Clin. Endocrinol. Metab. — 2005 — Vol. 19 — P. 525−546.
- Krahn L.E., Boeve B.F. et al. Hypocretin (orexin) and melatonin values in a narcoleptic-like sleep disorder after pinealectomy. // Sleep Medicine 2002 -Vol. 3−6-P. 521−523.
- Kreier F., Fliers E., Voshol P.J. et al. Selective parasympathetic innervation of subcutaneous and intra-abdominal fat functional implications. // J. Clin. Invest.-2002-Vol. 110-P. 1243−1250.
- Lanthaler M., Aigner F., Kinzl J. et al. Long-term results and complications following adjust- able gastric banding. // Obes. Surg. 2010 — Vol. 20 — P. 1078−1085.
- Lee M., Korner J. Review of physiology, clinical manifestations, and management of hypothalamic obesity in humans. // Pituitary 2009 — Vol. 12(2)-P. 87−95.
- Lee M., Wardlaw S.L. The central melanocortin system and the regulation of energy balance. // Front. Biosci. 2007 — Vol. 12 — P. 3994-^010.
- Leslie D.B., Kellogg T.A., Ikramuddin S. The surgical approach to management of pediatric obesity: when to refer and what to expect. // Rev. Endocr. Metab. Disord. 2009 — Vol. 10 -P. 215−229.
- Lin L., Faraco J., R. Li et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. // Cell 1999 — Vol. 98−3-P. 365−376.
- Lindholm J., Nielsen E.H. Craniopharyngioma: historical notes. // Pituitary -2009-Vol. 12(4)-P. 352−9.
- Lipton J., Megerian J. T, Kothare S.V. et al. Melatonin deficiency and disrupted circadian rhythms in pediatric survivors of craniopharyngioma. // Neurology 2009 — Vol. 73(4) — P. 323−5.
- Lonnqvist F., Arner P., Nordfors L., et al. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. // Nat. Med. 1995 — Vol.1 -P. 950−93.
- Lonnqvist F., Thorne A., Nilsell K. et al. A pathogenic role of visceral fat b3-adrenoreceptors in obesity. //J. Clin. Invest. 1995 — Vol. 95 — P. 1109−1116.
- Lustig R.H. Octreotide therapy of pediatric hypothalamic obesity: a doubleblind, placebo-controlled trial. // J. Clin. Endocrinol. Metab. 2003 — Vol. 88(6)-P. 2586−92.
- Lustig R.H., Post S.R. et al. Risk factors for the development of obesity in children surviving brain tumors. // J. Clin. Endocrinol. Metab. 2003 — Vol. 88(2)-P. 611−6.
- Lustig R.H. Childhood obesity: behavioral aberration or bio- chemical drive? Reinterpreting the First Law of Thermodynamics. // Nat. Clin. Pract. Endol. Metab. 2006 — Vol. 2 — P. 447158.
- Lustig R.H. et al. Treatment of hypothalamic obesity by laparoscopic truncal vagotomy: early experience. // Horm. Res. 2009 — Vol. 72 (suppl. 3) — P. 48.
- Mancini M.C. Metabolic syndrome in children and adolescents criteria for diagnosis. // Diabetol. Metab. Syndr. — 2009 — Vol. 1(1) — P. 20.
- Marcus C.L., Trescher W.H., et al. Secondary narcolepsy in children with brain tumors. // Sleep 2002 — Vol. 25 — 4 — P. 435−439.
- Martins A.C., Souza K.L. et al. Adrenal medullary function and expression of catecholamine-synthesizing enzymes in mice with hypothalamic obesity. // Life Sci. 2004 — Vol. 74 — P. 3211−3222.
- Mason P.W., Krawiecki N., Meacham L.R. The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. // Archives of Pediatrics and Adolescent Medicine 2002 — Vol. 156(9) — P. 887−892.
- McLaughlin T. Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls. // J. Clin. Endocrin. Metab. -2004 Vol. 89(4) — P. 1630−1635.
- Merchant T.E., Kiehna E.N. et al. Craniopharyngioma: the st. Jude children’s research hospital experience 1984−2001. // Int. J. Radiat. Oncol. Biol. Phys. -2002-Vol. 53(3)-P. 533−42.
- Miller J., Rosenbloom A., Silverstein J. Childhood Obesity. // J. Clin. Endocrin. Metab. 2004 — Vol. 89(9) — P. 4211−4218.
- Milone L., Strong V., Gagner M. Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for the super-obese patient (BMI > 50). // Obes. Surg. 2005 — Vol. 15 — P. 612−617.
- Minami S., Asai M., Iwahori K. et al. Three cases of metastatic meningeal carcinomatosis from lung cancer. // Nihon Kokyuki Gakkai Zasshi 2002 -Vol. 40(6) -P. 513−519.
- Minniti G., Saran F. et al. Fractionated stereotactic conformai radiotherapy following con- servative surgery in the control of craniopharyngiomas. // Radiother. Oncol. 2007 — Vol. 82 — P. 90 -95.
- Montague C.T., Prins J.B., Sanders L. et al. Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. // Diabetes 1997 — Vol. 46 — P. 342−347.
- Montaurier C., Morio B., Bannier S. et al. Mechanisms of body weight gain in patients with Parkinson’s disease after subthalamic stimulation. // Brain -2007-Vol. 130-P. 1808−1818.
- Moraes J.C., Coope A., Morari J. et al. High-fat diet induces apoptosis of hypothalamic neurons. // PLoS ONE 2009 — Vol. 4 — P. 50−56.
- Muller H.L., Gebhardt R. et al. Secondary narcolepsy may be an underrated cause of increased daytime sleepiness in obese patients after childhood craniopharyngioma. // Journal of Pediatric Endocrinology & Metabolism -2006-Vol. 19-P. 423429.
- Muller H.L., Bruhnken G. et al. Longitudinal study on quality of life in 102 survivors of childhood craniopharyngioma. // Childs. Nerv. Syst. 2005 -Vol. 21(11)-P. 975−80.
- Muller H.L., Bueb K., Bartels U. et al. Obesity after childhood craniopharyngioma-german multicenter study on preoperative risk factors and quality of life. // Klin. Padiatr. 2001 — Vol. 213 — P. 244−9.
- Muller H.L., Faldum A. et al. Functional capacity, obesity and hypothalamic involvement: cross-sectional study on 212 patients with childhood craniopharyngioma. // Klin. Padiatr. 2003 — Vol. 215(6) — P. 310−4.
- Muller H.L., Gebhardt U. et al. Current strategies in diagnostics and endocrine treatment of patients with childhood craniopharyngioma during follow-up-recommendations in KRANIOPHARYNGEOM 2000. // Onkologie 2005 — Vol. 28(3) — P. 150−6.
- Muller H.L., Gebhardt U. et al. Prognosis and sequela in patients with childhood craniopharyngioma results of HIT-ENDO and update on KRANIOPHARYNGEOM 2000. // Klin. Padiatr. — 2004 — Vol. 216(6) — P. 343−8.
- Muller H.L., Gebhardt U. et al. Functional capacity and body mass index in patients with sellar masses-cross-sectional study on 403 patients diagnosed during childhood and adolescence. // Childs Nerv. Syst. 2005 — Vol. 21(7) P. 539−45.
- Muller H.L., Gebhardt U., Wessel V. et al. First experiences with laparoscopic adjustable gastric banding (LAGB) in the treatment of patients with childhood craniopharyngioma and morbid obesity. // Klin. Padiatr. -2007 Vol. 219 — P. 323−325.
- Muller H.L., Handwerker G. et al. Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness. // Cancer Causes Control 2006 — Vol. 17(4) — P. 583−9.
- Muller H.L., Handwerker G. et al. Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients. // J. Clin. Endocrinol. Metab. 2002 — Vol. 87(8) — P. 3993−6.
- Muller H.L., Heinrich M., Bueb K. et al. Perioperative dexamethasone treatment in childhood craniopharyngioma-influence on short-term and long-term weight gain. // Exp. Clin. Endocrinol. Diabetes 2003 — Vol. Ill — P. 330−334.
- Muller H.L. Childhood craniopharyngioma diagnostic and therapeutic strategies. // Monatsschr Kinderheilkunde — 2003 — Vol. 151 — P. 1056−63.
- Muller H.L. Childhood craniopharyngioma current concepts in diagnosis, therapy and follow-up. // Nat. Rev. Endocrinol. — 2010 — Vol. 6(11) — P. 60 918.
- Muller H.L. Childhood craniopharyngioma: current strategies in laboratory diagnostics and endocrine treatment. // Lab. Med. 2003 — Vol. 27 — P. 37 785.
- Muller H.L. Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up. // Horm. Res. 2008 — Vol. 69(4) — P. 193−202. 71.
- Muller H.L. Increased daytime sleepiness in patients with childhood craniopharyngioma and hypothalamic tumor involvement: review of theliterature and perspectives. // Int. J. Endocrinol. 2010 — Vol. 10 — P. 51 960?.
- Miiller H.L. More or less? Treatment strategies in childhood craniopharyngioma. // Child’s Nervous System 2006 — Vol. 22(2) — P. 156−7.
- Murata J.I., Sawamura Y. et al. Twenty-four hour of melatonin in patients with a history of pineal and/or hypothalamo-neurohypophyseal germinoma. // Journal of Pineal Research 1998 — Vol. 25(3) — P. 159−166.
- Murphy K.G., Bloom S.R. Gut hormones and the regulation of energy homeostasis. // Nature 2006 — Vol. 444 — P. 854−859.
- Nishino S., Ripley B., Overeem S. et al. Hypocretin (orexin) deficiency in human narcolepsy. // Lancet 2000 — Vol. 355 — P. 91−97.
- Oikonomou E. et al. Beta-catenin mutations in craniopharyngiomas and pituitary adenomas. // J. Neurooncol. 2005 — Vol. 73 — P. 205−9.
- Ostlund E., Yang J.W., Klein S. et al. Relation between plasma leptin level and body fat, gender, diet, age, and metabolic covariates. // J. Clin. Endocrinol. Metab. 1996 — Vol. 81 — P. 3909−3913.
- Ostrowska Z., Buntner B., Banas I. et al. Circadian variations of salivary melatonin levels in women of reproductive and post- menopausal age with gynoid and android obesity. // Endocrine Regulations 1996 — Vol. 30(3) — P. 143−152.
- Pettorini B.L. et al. The role of inflammation in the genesis of the cystic component of craniopharyngiomas. // Childs Nerv. Syst. 2010 — Vol. 26(12) -P. 1779−84.
- Peyron C., Faraco J., Rogers W. et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. // Nature Medicine 2000 — Vol. 6(9) — P. 991−997.
- Pi-Sunyer F.X., Aronne L.J. et al. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. // JAMA -2006-Vol. 295-P. 761−775.
- Puget S., Garnett M., Wray A. et al. Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. // J. Neurosurg. 2007 — Vol. 106 (suppl. 1) — P. 3−12.
- Ramos A., Neto M.G., Galvao M. et al. Laparoscopic greater curvature plication: initial results of an alternative restrictive bariatric procedure. // Obes. Surg. 2010 — Vol. 20 — P. 913−918.
- Reeves A.G., Plum F. Hyperphagia, rage, and dementia accompanying a ventromedial hypothalamic neoplasm. // Arch. Neurol. 1969 — Vol. 20 — P. 616−624.
- Rennert J., Doerfler A. Imaging of sellar and parasellar lesions. // Clin. Neurol. Neurosurg. 2007 — Vol. 109 — P. 111−124.
- Rios E.R., Venancio E.T., Rocha N.F. et al. Melatonin: pharmacological aspects and clinical trends. // Int. J. Neurosci. 2010 — Vol. 120(9) — P. 58 390.
- Ronnemaa T., Karonen S.L., Rissanen A. et al. Relation between plasma leptin levels and measures of body fat in identical twins discordant for obesity. // Ann. Intern. Med. 1997 — Vol. 126 — P. 26−31.
- Rossi A. et al. Neuroimaging of pediatric craniopharyngiomas: a pictorial essay. // J. Pediatr. Endocrinol. Metab. 2006 — Vol. 19 (suppl. 1) — P. 299 319.
- Roth C.L., Hunneman D.H. et al. Reduced sympathetic metabolites in urine of obese patients with craniopharyngioma. // Pediatr. Res. 2007 — Vol. 61(4) — P. 496−501.
- Rushing E.J., Giangaspero F. et al. Craniopharyngioma. // In: Louis D.N., Ohgaki H., Wiestler O.D., Cavanee W.K. WHO classification of tumours of the central nervous system. Lyon: IARC Press 2007 — P. 238−240.
- Sahakitrungruang T., Klomchan T. et al. Obesity, metabolic syndrome, and insulin dynamics in children after craniopharyngioma surgery. // Eur. J. Pediatr. 2011 — Vol. 170(6)-P. 763−9.
- Schofl C., Schleth A., Berger D. et al. Sympathoadrenal counterregulation in patients with hypothalamic craniopharyngioma. // J. Clin. Endocrinol. Metab. 2002-Vol. 87-P. 624−629.
- Schultes B., Ernst B. et al. Distal gastric bypass surgery for the treatment of hypothalamic obesity after childhood craniopharyngioma. // European Journal of Endocrinology 2009 — Vol. 161 (1) — P. 201 -6.
- Scomparin D.X., Grassiolli S. et al. Swim training applied at early age is critical to adrenal medulla catecholamine content and to attenuate monosodium L-glutamate-obesity onset in mice. // Life Sci. 2006 — Vol. 79 -P. 2151−2156.
- Shimabukuro M., Koyama K., Chen G. et al. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. // Natl. Acad. Sci. USA -1997-Vol. 94- P. 4637−4641.
- Simoneau-Roy J, O’Gorman C. et al. Insulin sensitivity and secretion in children and adolescents with hypothalamic obesity following treatment for craniopharyngioma. // Clinical Endocrinology 2010 — Vol. 72(3) — P. 36 470.
- Smith D.K., Sarfeh J., Howard L. Truncal vagotomy in hypothalamic obesity. //Lancet- 1983 -Vol. 1 P. 1330−1331.
- Smith T. Cataplexy in association with meningeomas. // Acta Neurologica Scandinavica. Supplementum 1983 — Vol. 67 (94) — P. 45−47.
- Stahl S.M., Layzer R.B., Aminoff M.J. Continuous cataplexy in a patient with a midbrain tumor: the limp man syndrome. // Neurology 1980 — Vol. 30(10) -P. 1115−1118.
- Steinberger J., Steffen L., Jacobs D.R. et al. Relation of Leptin to Insulin Resistance Syndrome in Children. // Obes. Res. 2003 — Vol. 11 — P. 11 241 130.
- Swaab D.F. Prader-Willi syndrome and the hypothalamus. // Acta. Paediatr. -1997-Vol. 423-P. 50−54.
- Swaab D.F., Gooren L.J., Hofman M.A. The human hypothalamus in relation to gender and sexual orientation. // Prog. Brain. Res. 1992 — Vol. 93 — P. 205−217.
- Tamarkin L., Abastillas P. et al. The daily profile of plasma melatonin in obese and Prader-Willi syndrome children. // Journal of Clinical Endocrinology and Metabolism 1982 — Vol. 55 (3) — P. 491−495.
- Tartaglia L. The leptin receptor. // J. Biol. Chem. 1997 — Vol. 272 — P. 60 936 096.
- Thannickal T.C., Moore R.Y., Nienhuis R. et al. Reduced number of hypocretin neurons in human narcolepsy. // Neuron 2000 — Vol. 27(3) — P. 469−474.
- Tiosano D., Eisentein I. et al. 11 beta-hydroxysteroid dehydrogenase activity in hypothalamic obesity. // J. Clin. Endocrinol. Metab. 2003 — Vol. 88(1) -P. 379−84.
- Tomita T., Bowman R.M. Craniopharyngiomas in children: Surgical experience at children’s memorial hospital. // Childs Nerv. Syst. 2005 — Vol. 21(8−9)-P. 729−46.
- Trivin C., Busiah K., Mahlaoui N. et al. Childhood craniopharyngioma: greater hypothalamic involvement before surgery is associated with higherhomeostasis model insulin resistance index. // BMC Pediatr. 2009 — Vol. 9 -P. 24.
- Vinchon M., Weill J., Delestret I. et al. Craniopharyngioma and hypothalamic obesity in children. // Childs Nerv. Syst. 2009 — Vol. 25(3) — P. 347−52.
- Warmuth-Metz M., Gnekow A.K., Muller H., Solymosi L. Differential diagnosis of suprasellar tumors in children. // Klin. Padiatr. 2004 — Vol. 216(6)-P. 323−30.
- Wilding J., Van Gaal L. et al. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects. // Int. J. Obes. Relat. Metab. Disord. 2004 — Vol. 28 — P. 1399−1410.
- Woods A.J., Stock M.J. Leptin activation in hypothalamus. // Nature 1996 -Vol. 381 — P. 745.
- Wynne K., Stanley S. et al. Appetite control. // J. Endocrinol. 2005 — Vol. 184-P. 291−318.
- Yuldiz B.O. Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. // Proceedings of the National Academy of Sciences of the USA -2004 -Vol. 101(28)-P. 10 434−10 439.
- Zhang Y., Proenca R., Maffei M. et al. Positional cloning of the mouse obese gene and its human homologue. // Nature 1994 — Vol. 372 — P. 425−432.